Literature DB >> 16845793

Extracapsular spread in ipsilateral neck metastasis: an important prognostic factor in laryngeal cancer.

Bin Liu1, Chao Guan, Wen-Yue Ji, Zi-Min Pan.   

Abstract

OBJECTIVE: To evaluate the impact of extracapsular spread (ECS) in ipsilateral neck metastasis on prognosis and its related factors in laryngeal cancer.
METHODS: The study included 184 patients who underwent laryngectomy and simultaneous radical or modified radical neck dissection between January 1994 and December 1997 for laryngeal cancer. All of them had a complete 5-year follow-up. We used transparent lymph node detection and continuous slicing method on all neck dissection specimens. Kaplan-Meier model was used for survival analysis and the log-rank test was used to assess significance.
RESULTS: We found pathological neck metastases in 80 patients. Among them, 26 cases (32.5%) had ECS in ipsilateral neck. ECS incidence increased with advanced pathological N (pN) stages (pN1 3.7%, pN2a 25.0%, pN2b 50.0%, and pN2c 55.6%; P = 0.001). ECS incidence also increased with number of positive nodes (1 positive node 8.6%, 2 positive nodes 33.3%, 3 and more positive nodes 66.7%; P < 0.001). Incidences of contralateral neck metastases and ipsilateral neck recurrence in patients with ECS were higher than those in patients without ECS (46.2% vs. 24.1%, P = 0.046; 34.6% vs. 7.4%, P = 0.002). The 5-year survival rate of patients with ECS was significantly lower than that of patients without ECS (23.1% vs. 57.4%, P = 0.013).
CONCLUSION: ECS is an important prognostic factor in laryngeal cancer. Patients with ECS have a higher incidence of contralateral neck metastasis, so bilateral neck dissection should be selected.

Entities:  

Mesh:

Year:  2006        PMID: 16845793

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  1 in total

1.  Predictors of extracapsular spread in lymph node metastasis.

Authors:  Kadir Imre; Ercan Pinar; Semih Oncel; Caglar Calli; Bekir Tatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-27       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.